Unlock the potential of your healthcare industry equity research and financial analysis

Analyzing the risks and benefits of investments in a pharmaceutical or biotech company requires access to a variety of current data on drug products, pricing, prescription volume, market competition, and more. Medi-Span® Price Rx® from Wolters Kluwer is an efficient, effective resource that offers a broad spectrum of financial institutions' drug pricing data and analytical tools that help enhance equity research and streamline processes that keep you on the leading edge of financial markets.

Let's do a risk-benefit analysis

Access to current drug data can be the difference between quickly and efficiently evaluating an investment opportunity or not being prepared for the moment when it arises. A subscription to Price Rx Pro includes:

Don’t pay the price, know the price
Referential Drug Pricing
Organizations use Medi-Span® drug data and clinical screening modules to support appropriate medication decisions, help reduce prescribing errors, and optimize alert systems.
With Medi-Span® Price Rx®, you get immediate access to unbiased and trusted current and historic referential drug pricing data to support strategic decisions.
  • Would losing Price Rx make your job more difficult? 
[When asked if losing Price Rx would make the job more difficult:] Yessirree! It’s the best drug pricing database out there. It’s very clean and easy to use, reliable. I use it for WAC pricing, both absolute and growth. It’s my go-to source for drug pricing.
Salim Syed

Speak to an expert 

Please fill out the form and one of our experts will be in touch with you to discuss how Medi-Span can help your healthcare organization. 

Back To Top